Tirzepatide 20mg Injection Pen (pre – Filled 3ml Cartridge)

Genlabs Tirzepatide 20 mg Reusable Injection Pen is an advanced injectable medication used for the management of type 2 diabetes and obesity. It is administered via a reusable injection pen with a cartridge system, allowing precise dosing and convenient once-weekly administration. Tirzepatide is widely recognized for its dual-hormone mechanism, which delivers powerful metabolic and weight-management benefits.

How It Works?

Genlabs Tirzepatide 20mg is a dual-agonist peptide that activates two key metabolic hormone receptors:

GLP-1 (Glucagon-Like Peptide-1) receptor

GIP (Glucose-Dependent Insulinotropic Polypeptide) receptor

By stimulating both pathways, tirzepatide helps regulate appetite, improve insulin response, and optimize glucose metabolism. This dual action leads to reduced food intake, better blood sugar control, and significant weight loss by enhancing insulin sensitivity and supporting healthy energy balance.

Dosage :

Use only under medical supervision. Administered once weekly via subcutaneous injection. Treatment typically begins with a low starting dose.

The 20 mg / 3 mL cartridge is designed for flexible dose adjustment using a reusable pen

Injection sites include abdomen, thigh, or upper arm. Dosage schedules may vary depending on patient needs and treatment goals.

Benefits :

• Significant weight loss
• Improved blood glucose control
• Enhanced insulin sensitivity
• Reduced appetite and cravings
• Once-weekly dosing for better compliance
• Accurate and consistent dosing with a reusable pen

Side Effects :

Common side effects :

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Decreased appetite

Less common or serious effects :

• Hypoglycemia (especially when combined with insulin or sulfonylureas)
• Gastrointestinal discomfort during dose escalation
• Fatigue or dizziness

Most side effects are mild to moderate and tend to improve as the body adjusts to treatment.

Conclusion :

Genlabs Tirzepatide 20mg Reusable Injection Pen represents a major advancement in diabetes and weight-management therapy due to its dual GLP-1 and GIP receptor activity. With proven effectiveness, convenient once-weekly dosing, and a precision reusable pen system, tirzepatide offers an efficient and patient-friendly option for long-term metabolic control when used under proper medical guidance.